ML18065A735

From kanterella
Revision as of 16:59, 21 October 2019 by StriderTol (talk | contribs) (Created page by program invented by StriderTol)
Jump to navigation Jump to search
03/01/18, Letters to the Honorable John Barrasso and Greg Walden from Eugene Dacus, OCA Provides the Nrc'S Charter Renewal for the Advisory Committee on Medical Uses of Isotopes
ML18065A735
Person / Time
Issue date: 03/01/2018
From: Eugene Dacus
Office of Congressional Affairs
To: Barrasso J, Walden G
US Congress, US HR, Comm on Energy & Commerce, US SEN, Comm on Environment & Public Works
Chazell, Russ, SECY
Shared Package
ML18065A254 List:
References
Download: ML18065A735 (2)


Text

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON , D.C. 20555-0001 March 1, 2018 The Honorable John Barrasso Chairman, Committee on Environment and Public Works United States Senate Washington , D.C. 20510

Dear Mr. Chairman:

In accordance with the requirements of the Federal Advisory Committee Act, the Nuclear Regulatory Commission (NRC) is filing the charter for the Advisory Committee on Medical Uses of Isotopes (ACMUI). The ACMUI provides advice on policy and technical issues that arise in regulating medical use of byproduct material for diagnosis and therapy. The enclosed charter for this Committee updates the document previously filed by the NRC in March 2016 and extends the life of the Committee through March 2020.

Sincerely, Eugene Dacus, Director Office of Congressional Affairs

Enclosure:

As stated cc: Senator Tom Carper

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 March 1, 2018 The Honorable Greg Walden Chairman, Committee on Energy and Commerce United States House of Representatives Washington , D.C. 20515

Dear Mr. Chairman :

In accordance with the requirements of the Federal Advisory Committee Act , the U.S.

Nuclear Regulatory Commission (NRC) is filing the charter for the Advisory Committee on Medical Uses of Isotopes (ACMUI). The ACMUI provides advice on policy and technical issues that arise in regulating medical use of byproduct material for diagnosis and therapy. The enclosed charter for this Committee updates the document previously filed by the NRC in March 2016 and extends the life of the Committee through March 2020.

Sincerely, Eugene Dacus, Director, Office of Congressional Affairs

Enclosure:

As stated cc: Representative Frank Pallone